For infusion providers, helping a patient start therapy involves far more than scheduling a chair and administering a medication.
Before treatment begins, teams may need to verify benefits, determine a patient’s expected out-of-pocket responsibility, identify available financial resources, complete enrollment paperwork, and coordinate with assistance programs or foundations. For patients receiving high-cost therapies, navigating that process can have a significant impact on whether they are able to move forward with treatment.
The resources are out there. The challenge is connecting patients to them.
Only 3% of eligible patients use the financial assistance programs they qualify for. At the same time, 59% of patients don’t even know these programs exist[1].
For infusion centers, that disconnect matters. When patients miss available support, the consequences can extend beyond their out-of-pocket costs. Affordability barriers can contribute to delayed treatment starts, additional administrative work, missed appointments, and balances that become increasingly difficult to collect.
Closing that gap starts with understanding why so much available support remains out of reach.
The problem isn’t always eligibility
There is no shortage of complexity in medication affordability.
Depending on a patient’s insurance coverage, diagnosis, medication, and financial circumstances, support may be available through manufacturer copay programs, charitable foundations, patient assistance programs, or other resources.
Each comes with its own eligibility requirements and processes. Some require documentation from the patient. Others require action from the provider. Foundation funding can open and close quickly. Manufacturer programs and eligibility requirements can change. A patient’s insurance coverage or financial situation may change during treatment.
That creates a significant challenge for infusion teams.
Finding support cannot always be a one-time task completed before the first infusion. A patient who doesn’t qualify for a particular resource today may qualify later. A foundation that is closed this week could reopen next month. A change in coverage could create an entirely different set of options.
Without a consistent way to identify, screen, and monitor patients over time, opportunities can easily be missed.
What the 3% gap looks like inside an infusion center
Consider a patient who has been prescribed an infusion therapy and learns that their portion of the treatment will cost significantly more than expected.
The patient may qualify for financial support, but they don’t know the program exists. Unless the care team identifies the opportunity, the patient is left to navigate the cost on their own.
The patient may postpone scheduling while they determine whether they can afford treatment. They may call the infusion center with questions about their bill or benefits. Staff may begin searching manufacturer websites, foundation portals, and other resources for a solution.
If one isn’t found quickly, treatment could be delayed. The patient may face a balance they cannot comfortably pay. In some cases, cost may become a factor in whether they move forward with treatment at all.
For the infusion center, the same problem creates additional work for staff and introduces financial risk for the organization.
This is what makes medication affordability different from many other administrative functions. The patient experience, clinical journey, and financial health of the organization are closely connected.
Manual processes make the gap harder to close
Most infusion organizations recognize the importance of connecting patients with available resources. The challenge is doing it consistently across an entire patient population.
Many teams have developed processes that rely heavily on staff knowledge and manual work. Someone knows which manufacturer programs are available for frequently administered therapies. Another team member regularly checks foundation portals. A spreadsheet may be used to keep track of patients waiting for funds to open.
Those processes can work, particularly when experienced staff members know where to look and what to watch, but they become increasingly difficult to scale.
As an infusion organization grows, so does the number of patients who need to be screened, programs that need to be monitored, applications that need to be completed, and claims that need to be tracked.
Even highly experienced teams have finite time.
That means the question isn’t simply whether an infusion center offers financial navigation. It’s whether its process can reliably identify every patient who may qualify for support and continue looking for opportunities throughout the patient’s treatment journey.
The 3% figure suggests there is still significant room to improve that connection.
Moving from reactive to proactive support
Traditionally, financial support can become a priority when someone recognizes there is already a problem.
A patient says they cannot afford their responsibility. A clinician raises a concern. Treatment is delayed. A balance goes unpaid. Someone then begins looking for resources that might help.
But by that point, affordability has already become a barrier.
A more proactive approach starts earlier.
Instead of waiting for patients to raise their hands, infusion organizations can use the information already available about a patient’s therapy, insurance coverage, and expected financial responsibility to identify potential needs and available resources.
Technology can help make that possible at scale.
Automated screening can help identify patients who may qualify for assistance. Program matching can reduce the amount of time staff spend searching for resources individually. Real-time monitoring can help teams respond when foundation funding becomes available. Digital enrollment workflows can reduce some of the administrative work required to move patients from identification to enrollment.
The purpose isn’t to remove people from the process. Financial navigation still requires expertise, judgment, and human interaction with patients.
Technology can help make sure staff know where that attention is needed.
For infusion centers, where teams are already balancing benefits verification, prior authorization, scheduling, billing, and numerous other responsibilities, that distinction matters.
Look beyond the copay card
For many infusion organizations, manufacturer copay programs are already a familiar part of the affordability strategy. They can provide significant support for eligible commercially insured patients.
But they represent only one part of the available assistance landscape.
Charitable foundations, patient assistance programs, and other resources can create additional opportunities for patients who may not qualify for traditional copay support. This can be particularly important when serving Medicare and other government-insured populations.
A strong financial navigation strategy considers the full range of resources available to a patient.
It also continues looking.
A patient may have no available foundation support when they first begin treatment, for example, but that doesn’t necessarily mean no support will become available. The ability to monitor funding and respond when circumstances change can help infusion teams capture opportunities that a one-time search might miss.
This is where the difference between having a financial assistance process and having a scalable financial navigation strategy becomes particularly clear.
Make affordability part of the patient journey
Patients shouldn’t need to understand the financial assistance ecosystem to access the medication they have been prescribed.
Many don’t know what programs exist, whether they qualify, or even what questions to ask. If 59% of patients aren’t aware that these programs are available, relying on patients to initiate the conversation will inevitably leave people behind.
Infusion organizations have an opportunity to make affordability support a more integrated part of the patient journey.
That means identifying potential needs earlier, screening patients consistently and making it easier for staff to connect patients with relevant resources.
TailorMed Core is built for exactly that work. It gives care teams a single system for identifying patients who may need support, matching them to available programs, managing enrollment and monitoring funds over time, integrated directly with the health system’s existing EMR, RCM, and other systems of record.
The value isn’t automation for its own sake. It’s giving infusion teams a more scalable way to find opportunities that would otherwise be difficult to uncover manually, across an entire patient population instead of one chart at a time.
When the technology handles more of the searching and monitoring, staff can focus their expertise where it matters most: helping patients navigate the path to treatment.
Closing the 3% gap
The fact that only 3% of eligible patients use the financial assistance programs they qualify for points to a problem that deserves attention across healthcare.
For infusion providers, it also presents an opportunity.
Thousands of resources exist to help patients afford their medications, but those programs can only make a difference when patients are connected to them.
Closing the gap requires looking beyond whether financial assistance is technically available and asking how reliably an organization can identify it for the people who qualify.
How are patients screened for support? How are available programs identified? Who is monitoring foundation funding? What happens when a patient’s circumstances change? How quickly can staff move from finding an opportunity to completing enrollment? And how many eligible patients might never enter the process because no one knows they need help?
Improving those processes can create benefits across the infusion experience. Patients have a better chance of accessing available support. Staff spend less time searching across disconnected resources. Organizations can reduce avoidable financial exposure. Most importantly, cost is less likely to become another obstacle between a patient and their prescribed treatment.
The resources already exist.
The next step is making sure more than 3% of the patients who qualify can access them.
[1]TailorMed Data 2026
Author: Jennifer Martin, VP of Marketing at TailorMed
For more infusion insights, tune into the WeInfuse podcast, download our magazine, and subscribe to our blog.
Additionally, see how WeInfuse is saving infusion operators both time and money with our ROI Calculators.
